Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial*

Abstract

In the present study, levosimendan infusion reduced the incidence of heart failure in cardiac surgery patients but was associated with arterial hypotension and increased requirement of vasopressor agents postoperatively. Improved mortality or morbidity was not demonstrated.